Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Surg Endosc ; 38(6): 3470-3477, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38769187

ABSTRACT

BACKGROUND: Soilage of the surgical endoscope occurs frequently during minimally invasive surgery. The resultant impairment of visualization of the surgical field compromises patient safety, prolongs operative times, and frustrates surgeons. The standard practice for cleaning the surgical camera involves a disruption in the conduct of surgery by completely removing the endoscope from the field, manually cleaning its lens, treating it with a surfactant, and reinserting it into the patient; after which the surgeon resumes the procedure. METHODS: We developed an automated solution for in vivo endoscope cleaning in minimally invasive surgery- a port that detects the position of the endoscope in its distal lumen, and precisely and automatically delivers a pressurized mist of cleaning solution to the lens of the camera. No additions to the scope and minimal user interaction with the port are required. We tested the efficacy of this troCarWash™ device in a porcine model of laparoscopy. Four board-certified general surgeons were instructed to soil and then clean the laparoscope using the device. Representative pre- and post-clean images were exported from the surgical video and clarity was graded (1) digitally by a canny edge detection algorithm, and (2) subjectively by 3 blinded, unbiased observers using a semi-quantitative scale. RESULTS: We observed statistically significant improvements in clarity by each method and for each surgeon, and we noted significant correlation between digital and subjective scores. CONCLUSION: Based on these data, we conclude that the troCarWash™ effectively restored impaired visualization in a large animal model of laparoscopy.


Subject(s)
Laparoscopy , Laparoscopy/methods , Laparoscopy/instrumentation , Animals , Swine , Laparoscopes , Equipment Contamination/prevention & control , Equipment Design
2.
J Neurosci ; 40(2): 459-477, 2020 01 08.
Article in English | MEDLINE | ID: mdl-31748376

ABSTRACT

α-Synuclein (α-Syn) accumulation is a pathological hallmark of Parkinson's disease. Duplications and triplications of SNCA, the gene coding for α-Syn, cause genetic forms of the disease, which suggests that increased α-Syn dosage can drive PD. To identify the proteins that regulate α-Syn, we previously performed a screen of potentially druggable genes that led to the identification of 60 modifiers. Among them, Doublecortin-like kinase 1 (DCLK1), a microtubule binding serine threonine kinase, emerged as a promising target due to its potent effect on α-Syn and potential druggability as a neuron-expressed kinase. In this study, we explore the relationship between DCLK1 and α-Syn in human cellular and mouse models of PD. First, we show that DCLK1 regulates α-Syn levels post-transcriptionally. Second, we demonstrate that knockdown of Dclk1 reduces phosphorylated species of α-Syn and α-Syn-induced neurotoxicity in the SNc in two distinct mouse models of synucleinopathy. Last, silencing DCLK1 in human neurons derived from individuals with SNCA triplications reduces phosphorylated and total α-Syn, thereby highlighting DCLK1 as a potential therapeutic target to reduce pathological α-Syn in disease.SIGNIFICANCE STATEMENT DCLK1 regulates α-Syn protein levels, and Dclk1 knockdown rescues α-Syn toxicity in mice. This study provides evidence for a novel function for DCLK1 in the mature brain, and for its potential as a new therapeutic target for synucleinopathies.


Subject(s)
Intracellular Signaling Peptides and Proteins/metabolism , Parkinson Disease/metabolism , Protein Serine-Threonine Kinases/metabolism , alpha-Synuclein/metabolism , Animals , Doublecortin-Like Kinases , Gene Knockdown Techniques , Humans , Mice , Mice, Inbred C57BL , Neurons/metabolism
3.
Am J Cancer Res ; 8(9): 1823-1836, 2018.
Article in English | MEDLINE | ID: mdl-30323974

ABSTRACT

ß-catenin is not only a key component of adherens junctions but also a transcriptional co-activator downstream of canonical Wnt signaling. The Wnt/ß-catenin pathway plays critical roles in animal development and tissue homeostasis, while mutation or overexpression of ß-catenin often leads to tumorigenesis and metastasis. Ubiquitination-mediated proteasomal degradation of ß-catenin is a key molecular event in the Wnt/ß-catenin pathway. Because deubiquitination of ß-catenin can stabilize ß-catenin and activate Wnt/ß-catenin signaling, targeting the ß-catenin deubiquitinase may provide a strategy for treating ß-catenin-driven cancers. Here, by screening a human deubiquitinase library, we identified USP2a as a deubiquitinase that binds, deubiquitinates, and stabilizes ß-catenin protein. USP2a promotes the nuclear accumulation and transcriptional activity of ß-catenin, leading to elevated expression of Wnt/ß-catenin target genes. Importantly, either genetic knockdown or pharmacological inhibition of USP2a leads to ß-catenin destabilization. These findings suggest that USP2a may serve as a therapeutic target for targeting the cancer-promoting protein ß-catenin.

SELECTION OF CITATIONS
SEARCH DETAIL
...